Company / Revenue per Share
IOVANCE BIOTHERAPEUTICS, INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.86
FY2025
5-year range
$0.01 / $0.86
FY2021-FY2025
Trend
+34.8%
vs FY2024
Sector context
#106 of 154
Health Care
What the data says
At $0.86, IOVANCE BIOTHERAPEUTICS, INC.'s revenue per share ranks #106 of 154 in the Health Care sector. Revenue per Share has increased for 3 consecutive years, from $0.00 in FY2018 to $0.86 in FY2025.
Based on SEC 10-K filings.
0.86 in FY2025.
Improved from $0.01 to $0.86 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 154 in Health CareTop 69% of 154This company $0.86 Sector average $10.35
▼
-91.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 34.8% year-over-year.
- Ranks #106 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | +34.8% |
| FY2024 | $0.64 | +10018.1% |
| FY2023 | $0.01 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026